Latest News Archive
Please select Category, Year, and then Month to display items
27 December 2021
|
Story Jóhann Thormählen
|
Photo Supplied
The Kovsie Annerie Dercksen is one of South Africa’s most promising youngsters and climbing the cricketing ladder.
She enjoyed every second of playing with some of her heroes and believes the exposure to international cricket will help her become a better player.
Annerie Dercksen is one of South Africa’s most promising youngsters and climbing the cricketing ladder.
Star from Beaufort West
This second-year Education student from the University of the Free State (UFS), who dreams of playing for the Momentum Proteas, represented the South African Emerging Women’s team three times in 2021.
The star from Beaufort West toured with the side to Bangladesh and also played against Zimbabwe and Thailand in One Day and T20 matches.
According to Dercksen, it is an incredible honour and privilege to be a part of a side.
She soaked up the experience and says everyone was willing to share their knowledge.
“I would have to say, sharing the field with some of my heroes and getting to work with some of the best coaches in the country are some of the highlights.”
She says each tour brought its own challenges and this helped her grow in the way she views and approaches the game.
“In Bangladesh we played against a well-established team in foreign conditions while facing a lot of spinners in spin friendly conditions. Personally, it was quite a challenge and I had to come back and work on some options, especially against spin.”
“Each tour brought its own challenges and this helped me grow in the way I view and approach the game.” - Annerie Dercksen
Coming through the ranks
The all-rounder has come through the ranks. She represented South-Western Districts at school level, played for the South African U19 side and is currently representing the Free State.
But Dercksen didn’t always dream cricket, especially not when playing ‘backyard’ cricket with her brother on the farm.
She didn’t even play for a team at school. “Until a boy from our primary school’s team got sick before a game. A teacher came to class and asked, ‘who can play cricket’, and I put up my hand.”
DNA sequencer launched at the UFS
2013-11-25
 |
| Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them. |
The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.
The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.
The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.
The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.
The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.
“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.
Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”